Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Concordia Healthcare closes US$67.6 million bought deal public offering

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Concordia Healthcare Corp.

On March 11, 2014, Concordia Healthcare Corp. (the “Corporation”) announced that it had completed its previously announced short form prospectus offering on a “bought deal” basis of 5,750,000 common shares (the “Common Shares”) of the Corporation, which included the exercise of an over-allotment option of 15%, for aggregate gross proceeds to the Corporation of $67,562,500 (the “Offering”). The Offering was completed at a price per Common Share of $11.75 by a syndicate of underwriters co-led by GMP Securities L.P. and Canaccord Genuity Corp. and including Barclays Capital Canada Inc., Beacon Securities Limited and Cormark Securities Inc. The Corporation was represented by a team of Fasken Martineau lawyers that included Rubin Rapuch, John Sabetti, Francesco Tallarico and Aidan Hyde (capital markets) and Mitchell Thaw (tax).

Team

    Subscribe

    Receive email updates from our team

    Subscribe